Crispr Therapeutics Ag (CRSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRSP | FOLD | LGND | ||
| Company | Crispr Therapeutics Ag | Amicus Therapeutics | Ligand Pharm | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 45.89 | 14.42 | 195.65 | ||
| High | 45.96 | 14.43 | 197.83 | ||
| Low | 44.12 | 14.42 | 188.67 | ||
| Latest | 44.34 | 14.43 | 192.64 | ||
| Change | -1.41 | +0.02 | -2.84 | ||
| % Change | -3.08% | +0.14% | -1.45% | ||
| Volume | 1,617,600 | 1,482,200 | 215,300 | ||
| 20-Day Average Volume | 2,311,525 | 3,844,195 | 249,035 | ||
| Previous Close | 45.75 | 14.41 | 195.48 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 50.42 | 14.38 | 205.97 | ||
| 20-Day Raw Stochastic | 1.33% | 100.00% | 10.11% | ||
| 20-Day Relative Strength | 38.34 | 73.90 | 44.66 | ||
| Weighted Alpha | +9.58 | +85.41 | +76.11 | ||
| Today's Opinion | 100% Sell | 100% Buy | 48% Buy | ||
| Previous Opinion | 100% Sell | 100% Buy | 56% Buy | ||
| Last Month's Opinion | 8% Buy | 100% Buy | 64% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.42% since 03/23/26 | +0.07% since 03/23/26 | -3.85% since 03/23/26 | ||
| Low | 44.12 on 03/30/26 | 14.40 on 03/25/26 | 188.67 on 03/30/26 | ||
| High | 48.80 on 03/26/26 | 14.43 on 03/30/26 | 208.89 on 03/25/26 | ||
| 1-Month | |||||
| %Chg | -26.27% since 02/27/26 | +0.42% since 02/27/26 | -2.86% since 02/27/26 | ||
| Low | 44.12 on 03/30/26 | 14.32 on 03/06/26 | 188.67 on 03/30/26 | ||
| High | 61.00 on 03/02/26 | 14.43 on 03/30/26 | 227.92 on 03/11/26 | ||
| 3-Month | |||||
| %Chg | -19.50% since 12/26/25 | +1.26% since 12/26/25 | -1.63% since 12/26/25 | ||
| Low | 44.12 on 03/30/26 | 14.20 on 01/05/26 | 175.89 on 01/13/26 | ||
| High | 61.76 on 02/26/26 | 14.43 on 03/30/26 | 227.92 on 03/11/26 | ||
| 6-Month | |||||
| %Chg | -28.10% since 09/26/25 | +75.12% since 09/26/25 | +13.50% since 09/26/25 | ||
| Low | 44.12 on 03/30/26 | 7.68 on 10/01/25 | 166.10 on 09/29/25 | ||
| High | 78.48 on 10/08/25 | 14.43 on 03/30/26 | 227.92 on 03/11/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,255,975 | 4,531,035 | 3,841,433 | ||
| Shares Outstanding, K | 95,985 | 314,001 | 19,941 | ||
| Annual Sales | 3,510,000 | 634,210,000 | 268,090,000 | ||
| Annual Net Income | -581,600,000 | -27,110,000 | 124,450,000 | ||
| Last Quarter Sales | 860,000 | 185,210,000 | 59,670,000 | ||
| Last Quarter Net Income | -130,610,000 | 1,690,000 | 44,780,000 | ||
| 60-Month Beta | 1.71 | 0.43 | 1.17 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.37 on 02/12/26 | 0.10 on 02/20/26 | 2.02 on 02/26/26 | ||
| Latest Earnings Date | 05/05/26 | 05/07/26 | 05/14/26 | ||
| Most Recent Dividend | N/A | N/A | 2.500 on 04/03/07 | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 480.33 | 33.53 | ||